col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


27 Ergebisse       Seite 1

 [1] 
Springer Science and Business Media LLC: Nature Reviews Rheumatology
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Feb―10 A direct link between SARS-CoV-2 and bone loss Sarah Onuora
2 [GO] 2025―Jan―28 Virome associations in autoimmunity and COVID-19 Maria Papatriantafyllou
3 [GO] 2024―Sep―05 Molecular mimicry links SARS-CoV-2 infection and MIS-C Jessica McHugh
4 [GO] 2024―Jun―05 COVID-19 linked to rise in anti-MDA5 autoimmunity Jessica McHugh
5 [GO] 2023―Okt―03 Pre-exposure prophylaxis reduces risk of COVID-19 Sarah Onuora
6 [GO] 2023―Apr―12 High risk of autoimmune diseases after COVID-19 Chetan Sharma, Jagadeesh Bayry
7 [GO] 2023―Mrz―28 Involvement of the secosteroid vitamin D in autoimmune rheumatic diseases and COVID-19 Maurizio Cutolo, Vanessa Smith, Sabrina Paolino, Emanuele Gotelli
8 [GO] 2022―Dez―14 COVID-19 vaccination in individuals with inflammatory rheumatic diseases Alla Skapenko, Hendrik Schulze-Koops
9 [GO] 2022―Okt―06 Publisher Correction: The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET Rosaria Talarico, Silvia Aguilera, Tobias Alexander, Zahir Amoura, Ana M. Antunes, Laurent Arnaud, et al. (+51)
10 [GO] 2022―Aug―11 NETs implicated in COVID-19 in kids and adults Sarah Onuora
11 [GO] 2022―Aug―11 SARS-CoV-2 vaccine safe for young patients Sarah Onuora
12 [GO] 2022―Feb―25 COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations Rebecca Grainger, Alfred H. J. Kim, Richard Conway, Jinoos Yazdany, Philip C. Robinson
13 [GO] 2022―Jan―11 How the COVID-19 pandemic has affected rheumatology research Paula Alba Moreyra, Francis Berenbaum, Debashish Danda, Bettina Grötsch, Simon R. Stones, Sowmya Viswanathan
14 [GO] 2021―Jun―01 NSAIDs not linked to worse COVID-19 outcomes Sarah Onuora
15 [GO] 2021―Apr―26 Systemic and organ-specific immune-related manifestations of COVID-19 Manuel Ramos-Casals, Pilar Brito-Zerón, Xavier Mariette
16 [GO] 2021―Feb―06 Immune cartography of macrophage activation syndrome in the COVID-19 era Dennis McGonagle, Athimalaipet V. Ramanan, Charlie Bridgewood
17 [GO] 2021―Jan―06 The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET Rosaria Talarico, Silvia Aguilera, Tobias Alexander, Zahir Amoura, Ana M. Antunes, Laurent Arnaud, et al. (+51)
18 [GO] 2020―Dez―18 Rheumatic disease and COVID-19: epidemiology and outcomes Kimme L. Hyrich, Pedro M. Machado
19 [GO] 2020―Nov―02 How COVID-19 is changing rheumatology clinical practice Eloisa Bonfá, Laure Gossec, David A. Isenberg, Zhanguo Li, Soumya Raychaudhuri
20 [GO] 2020―Okt―20 HCQ use not protective against SARS-CoV-2 Sarah Onuora
21 [GO] 2020―Okt―07 Removing barriers and disparities in health: lessons from the COVID-19 pandemic Emily Sirotich, Jonathan S. Hausmann
22 [GO] 2020―Jul―30 Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications Joan T. Merrill, Doruk Erkan, Jerald Winakur, Judith A. James
23 [GO] 2020―Jul―03 New data emerging on outcomes for patients with COVID-19 and rheumatic diseases Sarah Onuora
24 [GO] 2020―Jun―19 COVID-19 revisiting inflammatory pathways of arthritis Georg Schett, Bernhard Manger, David Simon, Roberto Caporali
25 [GO] 2020―Jun―04 Autoimmune and inflammatory diseases following COVID-19 Caroline Galeotti, Jagadeesh Bayry
26 [GO] 2020―Apr―30 Combating physical inactivity during the COVID-19 pandemic Ana Jéssica Pinto, David W. Dunstan, Neville Owen, Eloisa Bonfá, Bruno Gualano
27 [GO] 2020―Apr―02 The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic Philip C. Robinson, Jinoos Yazdany
 [1] 

27 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec